David Lamond - 01 Jun 2022 Form 4 Insider Report for Lucira Health, Inc.

Role
Director
Signature
/s/ Dan George, Attorney-in-Fact for David Lamond
Issuer symbol
N/A
Transactions as of
01 Jun 2022
Net transactions value
$0
Form type
4
Filing time
03 Jun 2022, 16:38:33 UTC
Previous filing
26 May 2022
Next filing
09 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LHDXQ Stock Option (right to buy) Award $0 +59,459 $0.000000 59,459 01 Jun 2022 Common Stock 59,459 $1.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option will vest upon the earlier of the one year anniversary of the grant date of June 1, 2022 or immediately prior to the next annual meeting.